We have found that AMT-E exerts intestinal anti-inflammatory activity in the colitis by increasing mucus production, inhibiting neutrophil infiltration, down-regulating TNF-α, IL-1β, and IL-10, as well as suppressing COX-2 and iNOS expression in the mouse colon tissue. This evidence concerns the gene IL10 and colitis.